Malignant mesothelioma of the peritoneum is rare, is an aggressive malignancy with an incidence of 1 case per 1,000,000, with approximately 20% of all mesotheliomas are peritoneal half of the cases have a history of asbestos exposure.
The diagnosis is delayed or is unclear because the clinical manifestations are nonspecific abdominal pain, bloating, postprandial fullness, ascites, weight loss and may be negative exposure to asbestos. (more…)
Peritoneal mesothelioma is an aggressive neoplasm with survival less than 1 year, usually classified as peritoneal carcinomatosis of unknown primary adenocarcinomas. The symptoms are nonspecific and in the case of women present with similar clinical data for advanced ovarian cancer: bloating, abdominal pain, postprandial fullness, constipation, ascites, abdominal tumor. In abdominal CT can be found ascites, omental thickening, peritoneal nodules.
The diagnosis is made by open surgery where there is a diffuse peritoneal carcinomatosis with ascites. The diagnosis is confirmed by immunohistochemistry. The surgical treatment is to achieve maximum debulking surgery of effort which is associated with better prognosis, however only 50% of cases may receive a successful cytoreductive surgery. (more…)
Etapificadora laparotomy was performed at 21 postoperative days in private hospitals with findings: peritoneal carcinomatosis with peritoneal implants and visceral pariestal colon, terminal ileum, omentum, and gastrocolic ligaments gastrohepatic, blind and extrinsic stenosis terminal ileum, peritoneal implants mesocolon, tuba, anterior of body, fundus.
Normal ovaries, 12 liters ascites fluid, thickened omentum aspect Omental Cake “tumor activity em both slides and dome diaphragm. Debulking surgery is performed best with extended right hemicolectomy, omentectomy and infracolic supra, abdominal hysterectomy with bilateral salpingo-oophorectomy, retroperitoneal lymph node dissection, peritoneal washing, biopsy slides and dome selective diaphragmatic anastomosis ileo-transverse terminal ended in two planes. (more…)
Protein HLJ1 is involved in slowing the progression of lung cancer, the researchers said.
Scientists at the National Taiwan University (China) have concluded that a protein called HLJ1 could function as tumor suppressor in non-small cell lung cancer.
The study, which publishes the Journal of the National Cancer Institute was based on increasing or blocking HLJ1 expression in lung carcinoma cells, and gene expression observed in tumors and adjacent tissue cells in 71 patients with cancer NSCLC.
The scientists found that, by stopping the proliferation of cancer cells HLJ1 lung, slowed the progression of cell division cycle and inhibited the ability of cells to move and invade other tissues. In addition, they found that patients with tumors that produced higher amounts of HLJ1 tended to lower cancer recurrence and a longer life than those whose tumors had lower protein presence.
In conclusion, the researchers say that this protein is a novel tumor suppressor of this type of lung cancer, which would benefit those who suffer from a complementary therapy and facilitate the design of individualized treatments. (more…)
There are a number of mesothelioma chemotherapy drugs are used in the treatment of a rare type of cancer, but have not been able to provide effective treatment for malignant mesothelioma. What most standard chemotherapy, chemotherapy drugs work by altering mesothelioma cell division or the initiation of programmed cell death (Apoptosis). For example, the anti-angiogenic chemotherapy mesothelioma inhibit the formation of new blood vessels (angiogenesis), preventing tumor formation a route for nutrients and oxygen necessary for metastasis (tumor growth and dissemination) of receive.
One of the drugs most conventional chemotherapy used to treat malignant mesothelioma is cisplatin. Cisplatin is a platinum-based treatment drug type, which is part of a family of three similar drugs (carboplatin, oxaliplatin, and others). Cisplatin DNA CROSS-links in a number of ways, which prevents the rapidly dividing cells to duplicate their DNA for cell division to capture. Cisplatin is now often used in combination with some new types of chemotherapy drugs such as Alimta (pemetrexed), Onconase (ranpirnase) and / or veglin. (more…)
Mesothelioma Chemotherapy uses chemicals to form deadly cancer called malignant mesothelioma treatment. A number of mesothelioma treatment options, no one to succeed in the fight against the disease. Mesothelioma Chemotherapy falls into two categories, traditional treatments and new mesothelioma.
Chemotherapy is used to treat cancer since early 1940, but that scientific progress and understanding of the nature of the disease led to further research and development of new targeted chemotherapy. Chemotherapy more effective when cancer cells are relatively young are not united in a solid tumor, it is extremely difficult to chemotherapy drugs impregnate a solid tumor mass.
If the disease is limited to a particular field, radiation is the best treatment possible. It is also used after surgery as consolidation therapy. All hemi-thorax is known to undergo radiation at times in harmony with chemotherapy. Thousands of patients have benefited from these mesothelioma treatment processes. The preventive function of radiation ensures the cessation of malignant cells to move. Chemotherapy, despite its drawbacks seemed to be the best treatment of mesothelioma in the days now. The processing procedure is not as hard as radiation or surgery. But it is a long process, physically and emotionally difficult for patients to endure. (more…)
The risk is even stronger there are more people living in the family, this case are close (father, mother, brother, sister), and that this case are young .
* Age: rare for fifty years, colorectal cancers are becoming quite common about 65 years.
* Heredity or mutations: the risk of colorectal cancer is higher if a relative has a colorectal cancers.
It has identified high-risk families, where people have a specific mutation that predisposes to cancer. These families represent only that 5% of colorectal cancers:
No familial adenomatous polyposis (FAP) where numerous polyps appear in all carriers of mutated APC gene. In adulthood, one of these polyps inevitably (more…)
The term chemotherapy can be used for all drugs used to treat the disease to describe, but the word is often used to refer to drugs used in cancer treatment. The term refers to treatment of disease with chemicals that kill cells. .
Typically, chemotherapy drugs work by targeting specific processes in cells that are in the process of dividing and growing fast, which prevents cell division, killing cancer cells. Unfortunately, these drugs are not very precise, and in addition to killing cancer cells, chemotherapy drugs also kill healthy cells, including those involved in its growth. (more…)
A List of schools not reaching the threshold of activity determined by the authorities for the surgery for certain cancers. This list would be end of estimates made by the newspaper from the national PMSI data, and methods of calculating the thresholds provided by the National Cancer Institute
The High Authority for Health (HAS) and the National Cancer Institute (Inca) announced the publication of the guide ALD30 (for protracted No. 30) for doctors on treating lung cancer and malignant pleural mesothelioma . The purpose of this guide is to explain to health professionals the optimal management and care pathway for patients admitted for cancer ALD. (more…)
In terms of treatment options for mesothelioma chemotherapy are available. Most chemotherapeutic drugs have specific side effects such as nausea, vomiting, loss of appetite, hair loss, and increased susceptibility to infections. No known symptoms during treatment with chemotherapy drugs must be reported to the doctor.
With mesothelioma, many use chemotherapy as a treatment. Understanding the various options available and chemotherapy often helps patients and their families, make the best decision for their personal situation. We offer a complete package detailing options and chemotherapy treatment, information on side effects of treatment, patients and families with the most recent information available. (more…)
© 2010 Malignant Mesothelioma. All right reserved.
